Stay updated on Crenolanib With Chemotherapy in Resistant FLT3 AML Clinical Trial
Sign up to get notified when there's something new on the Crenolanib With Chemotherapy in Resistant FLT3 AML Clinical Trial page.

Latest updates to the Crenolanib With Chemotherapy in Resistant FLT3 AML Clinical Trial page
- Check3 days agoChange DetectedThe page’s displayed revision/version number was updated from “v3.5.2” to “v3.5.3,” indicating a maintenance or software update without altering the recorded trial information.SummaryDifference0.1%

- Check11 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.1%

- Check18 days agoChange DetectedThe history shows the study is completed with updates to Study Status, Study Design, and Contacts/Locations. Earlier status and sponsor-related details were removed or revised to reflect the current record.SummaryDifference0.8%

- Check40 days agoChange DetectedAdded revision v3.5.0 to the record history and removed revision v3.4.3.SummaryDifference0.1%

- Check47 days agoChange DetectedA new Revision: v3.4.3 is now shown in the history. Revision: v3.4.2 has been removed.SummaryDifference0.1%

- Check75 days agoChange DetectedA new revision entry (v3.4.2) has been added to the record history. Older notices, including a government funding notice and Revision v3.4.1, were removed.SummaryDifference0.5%

Stay in the know with updates to Crenolanib With Chemotherapy in Resistant FLT3 AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Crenolanib With Chemotherapy in Resistant FLT3 AML Clinical Trial page.